[Chloasma during treatments with synthetic estroprogestagens].
D000328:Adult; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy*; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000209:etiology*; D011372:Progestins / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D011372:Progestins; D009640:Norethindrone
Le chloasma au cours des traitements par les oestroprogestatifs de synthese.